<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Med Biol Res</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Med. Biol. Res</journal-id><journal-id journal-id-type="publisher-id">bjmbr</journal-id><journal-title-group><journal-title>Brazilian Journal of Medical and Biological Research</journal-title></journal-title-group><issn pub-type="ppub">0100-879X</issn><issn pub-type="epub">1414-431X</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o Brasileira de Divulga&#x000e7;&#x000e3;o Cient&#x000ed;fica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26909786</article-id><article-id pub-id-type="pmc">4792505</article-id><article-id pub-id-type="other">00702</article-id><article-id pub-id-type="doi">10.1590/1414-431X20154646</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Investigation</subject></subj-group></article-categories><title-group><article-title>Dexmedetomidine decreases the inflammatory response to myocardial surgery
under mini-cardiopulmonary bypass</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bulow</surname><given-names>N.M.H.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Colpo</surname><given-names>E.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>R.P.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Correa</surname><given-names>E.F.M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Waczuk</surname><given-names>E.P.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Duarte</surname><given-names>M.F.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rocha</surname><given-names>J.B.T.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1"><label>1</label>Departamento de Bioqu&#x000ed;mica e Biologia Molecular, Programa de
P&#x000f3;s-gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias Biol&#x000f3;gicas - Bioqu&#x000ed;mica Toxicol&#x000f3;gica, Centro de Ci&#x000ea;ncias
Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, RS, Brasil</aff><aff id="aff2"><label>2</label>Departamento de Cirurgia, Centro de Ci&#x000ea;ncias da Sa&#x000fa;de, Universidade
Federal de Santa Maria, Santa Maria, RS, Brasil</aff><aff id="aff3"><label>3</label>Departamento de Qu&#x000ed;mica, Programa de P&#x000f3;s-gradua&#x000e7;&#x000e3;o em Qu&#x000ed;mica
Aplicada, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brasil</aff><aff id="aff4"><label>4</label>Departamento de Nutri&#x000e7;&#x000e3;o, Centro Universit&#x000e1;rio Franciscano, Santa
Maria, RS, Brasil</aff></contrib-group><author-notes><corresp>Correspondence: J.B.T. Rocha: <email>jbtrocha@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>49</volume><issue>4</issue><elocation-id>e4646</elocation-id><history><date date-type="received"><day>15</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>31</day><month>8</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p></license></permissions><abstract><p>Cardiopulmonary bypass (CPB) with extracorporeal circulation produces changes in the
immune system accompanied by an increase in proinflammatory cytokines and a decrease
in anti-inflammatory cytokines. We hypothesize that dexmedetomidine (DEX) as an
anesthetic adjuvant modulates the inflammatory response after coronary artery bypass
graft surgery with mini-CPB. In a prospective, randomized, blind study, 12 patients
(4 females and 8 males, age range 42-72) were assigned to DEX group and compared with
a conventional total intravenous anesthesia (TIVA) group of 11 patients (4 females
and 7 males). The endpoints used to assess inflammatory and biochemical responses to
mini-CPB were plasma interleukin (IL)-1, IL-6, IL-10, interferon (INF)-&#x003b3;, tumor
necrosis factor (TNF)-&#x003b1;, C-reactive protein, creatine phosphokinase, creatine
phosphokinase-MB, cardiac troponin I, cortisol, and glucose levels. These variables
were determined before anesthesia, 90 min after beginning CPB, 5 h after beginning
CPB, and 24 h after the end of surgery. Endpoints of oxidative stress, including
thiobarbituric acid reactive species and delta-aminolevulinate dehydratase activity
in erythrocytes were also determined. DEX+TIVA use was associated with a significant
reduction in IL-1, IL-6, TNF-&#x003b1;, and INF-&#x003b3; (P&#x0003c;0.0001) levels compared with TIVA
(two-way ANOVA). In contrast, the surgery-induced increase in thiobarbituric acid
reactive species was higher in the DEX+TIVA group than in the TIVA group (P&#x0003c;0.01;
two-way ANOVA). Delta-aminolevulinate dehydratase activity was decreased after CPB
(P&#x0003c;0.001), but there was no difference between the two groups. DEX as an adjuvant
in anesthesia reduced circulating IL-1, IL-6, TNF-&#x003b1;, and INF-&#x003b3; levels after mini-CPB.
These findings indicate an interesting anti-inflammatory effect of DEX, which should
be studied in different types of surgical interventions.</p></abstract><kwd-group><kwd>Cytokines</kwd><kwd>Systemic inflammatory response syndrome</kwd><kwd>Total intravenous anesthesia</kwd><kwd>Dexmedetomidine</kwd><kwd>Coronary artery bypass grafting surgery</kwd><kwd>Mini-cardiopulmonary bypass</kwd></kwd-group><counts><fig-count count="3"/><table-count count="1"/><equation-count count="0"/><ref-count count="35"/><page-count count="7"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Exacerbated immunoinflammatory responses to cardiopulmonary bypass (CPB) have been
compared with systemic inflammatory response syndrome (SIRS) (<xref rid="B01" ref-type="bibr">1</xref>
<xref rid="B02" ref-type="bibr">2</xref>
<xref rid="B03" ref-type="bibr">3</xref>). Surgical trauma, cardiac arrest, aortic
cannulation, exposure of blood to nonphysiological surfaces of the cardiopulmonary
bypass circuit, and ischemia/reperfusion injury trigger the excessive release of
proinflammatory factors (cytokines, endothelins, platelet-activating factors, and
endothelial and leukocyte adhesion molecules) (<xref rid="B04" ref-type="bibr">4</xref>
<xref rid="B05" ref-type="bibr">5</xref>
<xref rid="B06" ref-type="bibr">6</xref>
<xref rid="B07" ref-type="bibr">7</xref>). An atypical inflammatory response observed in
SIRS and after CPB has been reported to be associated with oxidative stress (<xref rid="B04" ref-type="bibr">4</xref>,<xref rid="B08" ref-type="bibr">8</xref>,<xref rid="B09" ref-type="bibr">9</xref>).</p><p>Anesthetic agents can exert clinical benefits during and after surgery (<xref rid="B05" ref-type="bibr">5</xref>,<xref rid="B09" ref-type="bibr">9</xref>
<xref rid="B10" ref-type="bibr">10</xref>
<xref rid="B11" ref-type="bibr">11</xref>
<xref rid="B12" ref-type="bibr">12</xref>
<xref rid="B13" ref-type="bibr">13</xref>). Optimistically, the ideal anti-inflammatory
anesthetic should reduce complications and mortality resulting from SIRS-like
postoperative responses. Alpha 2-adrenergic receptor agonists have been used in
anesthesia because of their sedative, analgesic, hemodynamic-stabilizing, and
sympatholytic effects (<xref rid="B09" ref-type="bibr">9</xref>,<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>). In addition, the
stress response to surgery can be modulated by postsynaptic central &#x003b1; 2-adrenergic
receptor activation (<xref rid="B16" ref-type="bibr">16</xref>). However, only a few
studies have investigated the anti-inflammatory properties of dexmedetomidine (DEX)
after coronary artery bypass graft (CABG) surgery with mini-CPB (<xref rid="B09" ref-type="bibr">9</xref>,<xref rid="B16" ref-type="bibr">16</xref>
<xref rid="B17" ref-type="bibr">17</xref>
<xref rid="B18" ref-type="bibr">18</xref>
<xref rid="B19" ref-type="bibr">19</xref>).</p><p>Safe and effective agents with anti-inflammatory properties to be used as anesthetics in
major surgeries need to be identified (<xref rid="B05" ref-type="bibr">5</xref>,<xref rid="B09" ref-type="bibr">9</xref>). In this regard, DEX is considered as a promising
candidate because &#x003b1; 2-adrenergic agonists have been reported to modulate inflammatory
responses (<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B16" ref-type="bibr">16</xref>
<xref rid="B17" ref-type="bibr">17</xref>
<xref rid="B18" ref-type="bibr">18</xref>
<xref rid="B19" ref-type="bibr">19</xref>).</p><p>We hypothesize that DEX in association with a conventional total intravenous anesthesia
(TIVA) (infusion of propofol and sufentanil) decreases the inflammatory response
associated with CABG surgery. To test this hypothesis, we measured interleukin (IL)-1,
IL-6, IL-10, tumor necrosis factor (TNF)-&#x003b1;, and interferon (IFN)-&#x003b3; levels as endpoints
of inflammation in patients undergoing CABG surgery. Because the inflammatory response
can trigger oxidative stress, two biochemical endpoints of oxidative stress,
thiobarbituric acid reactive substances (TBARS) (<xref rid="B20" ref-type="bibr">20</xref>) and delta-aminolevulinate dehydratase (ALA-D) activity (<xref rid="B21" ref-type="bibr">21</xref>), were also determined in erythrocytes.</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><p>Institutional ethics review board approval (Protocol #23081.015056/2009-58, Approval
#0271.0.243.000-9, Research Ethical Committee of UFSM in January 2010) and written
informed consent from patients were obtained. A total of 30 clinical American Society of
Anesthesiologists class II and III patients (42-72 years old) were included in the
study. They were scheduled for CABG surgery under mini-CPB and randomly assigned to the
conventional TIVA (propofol/sufentanil) group (15 patients) or to the TIVA with DEX
(propofol/sufentanil/DEX) (TIVA+DEX; 15 patients) group. The surgery team, surgeon, and
perfusionist were the same for all of the patients. Patients were recruited during a
period of 2 years during which data were collected.</p><p>Exclusion criteria included the following: severe ventricular dysfunction (left
ventricular ejection fraction &#x0003c;40%), reintervention surgery, requirement for blood
products from the start of CPB, preoperative history of liver or kidney dysfunction,
immunological disease, preoperative intake of corticosteroids or anti-inflammatory drugs
(except for acetylsalicylic acid), and a history of recent myocardial infarction (last 2
weeks).</p><p>Patients who were allocated to the TIVA group were anesthetized with TIVA in
target-controlled infusion of propofol as a hypnotic (TCI infusion system,
Diprifusor<sup>&#x000af;</sup>; AstraZeneca, Germany). Propofol was infused to an initial
target blood concentration of 4 &#x003bc;g/mL during the induction and maintenance of
anesthesia. The target dose was based on bispectral (BIS) index monitoring (i.e., the
dose was selected to have BIS values between 45 and 55). Sufentanil was infused at a
dose of 0.5 to 1 &#x000b5;g/kg (induction) and maintained at 0.5 to 1
&#x000b5;g&#x000b7;kg<sup>-1</sup>&#x000b7;h<sup>-1</sup> during surgery. Muscle relaxation for tracheal
intubation was obtained with 0.1 mg/kg pancuronium at induction and an additional
one-third of this dose was provided if necessary.</p><p>Patients who were allocated to the TIVA+DEX group were anesthetized with TIVA in
target-controlled infusion of propofol as a hypnotic (TCI infusion system, Diprifusor).
The initial target blood concentration of propofol was 4 &#x003bc;g/mL for induction and
maintenance of anesthesia. Sufentanil was administered at 0.5 to 1 &#x000b5;g/kg during
induction and at rates of 0.5 to 1 &#x000b5;g&#x000b7;kg<sup>-1</sup>&#x000b7;h<sup>-1</sup> during the
maintenance period. DEX was infused at 0.3 &#x000b5;g&#x000b7;kg<sup>-1</sup>&#x000b7;h<sup>-1</sup> during the
entire surgery (induction and maintenance of anesthesia). The dose of DEX was lower than
the average dose that is commonly used in surgeries to prevent bradycardia and because
it was used together with sufentanil and propofol. Muscle relaxation for tracheal
intubation was obtained with 0.1 mg/kg pancuronium at induction and an additional
one-third of the dose was provided if necessary. Surgeons working in the operation room
and the medical team in the intensive care unit (ICU) were blind to treatment
protocols.</p><p>Systemic arterial blood pressure was measured via radial artery catheterization. A
Swan-Ganz catheter (Edwards Lifesciences LLC, USA) was inserted for determining central
venous pressure, pulmonary capillary pressure, and the cardiac index. Hemodynamic
parameters were periodically monitored for a period of 24 h after surgery to detect and
adjust arterial blood pressure and the cardiac index to be within 20% of that found at
baseline (pre-operation level). Cardioscopy, pulse oximetry, expired CO<sub>2</sub>
levels, nasopharynx temperature, and the BIS index were monitored. The surgery was
conducted under mini-CPB and mild hypothermia (34-35&#x000b0;C). Blood samples were collected to
measure arterial gases, hemodilution, and electrolytes.</p><p>For determination of biochemical and inflammatory markers, arterial blood was sampled at
radial catheterization before induction of anesthesia (baseline), 90 min after starting
mini-CPB (during surgery), 5 h after starting mini-CPB (within 2-3 h after the end of
surgery), and 24 h after the end of surgery.</p><p>Cytokines (IL-1, IL-6, IL-10, TNF-&#x003b1;, and INF-&#x003b3;) were measured by chemical analysis
(commercial kits: eBioscience&#x000af;, USA). Plasma levels of C-reactive protein were measured
by immunoassay (Dimension&#x000af;; Siemens, Healthcare Diagnostics Inc., USA). We used a
chemiluminescent method (Immulite&#x000af;; Siemens, Healthcare Diagnostics Inc.) for
determination of cardiac troponin I levels. Creatine phosphokinase (CPK) and CPK-MB
levels were measured by enzymatic methods (Dimension&#x000af;; Siemens, Healthcare Diagnostics
Inc.), cortisol levels were determined using a chemiluminescent enzyme immunoassay
(Immulite&#x000af;; Siemens, Healthcare Diagnostics Inc.), and glucose levels were measured by a
biochromatic method (Dimension&#x000af;; Siemens, Healthcare Diagnostics Inc.).</p><p>TBARS (<xref rid="B20" ref-type="bibr">20</xref>) and ALA-D activity (<xref rid="B21" ref-type="bibr">21</xref>) in erythrocytes were determined as described
previously.</p><p>Plasma samples were coded, and the investigators were blind regarding the treatment
regimen. Similarly, all hemodynamic data were collected by trained personnel who were
not authors of this study and blind to the anesthetic regimen used. They also recorded
the duration of the surgery, the duration of mini-CPB, time for extubation, time in the
ICU, and time for in-hospital stay. Postoperative complications and necessity of
inotropic support with dobutamine, dopamine, and noradrenaline (i.e., the use of two or
more of these inotropic drugs for hemodynamic stability) were recorded. However, their
use was necessary only in three patients in the TIVA group and in two in the TIVA+DEX
group.</p><p>All continuous data are reported as means&#x000b1;SD. Statistical analysis was performed by
two-way ANOVA (two anesthetic procedures &#x000d7; four sampling times) with time and treatment
as the two factors. Values were considered to be statistically significant when P was
&#x0003c;0.05.</p></sec><sec sec-type="results"><title>Results</title><p>The characteristics of the two groups were similar regarding age, weight, height,
comorbidities, mini-CPB time, total surgery time, time for extubation, time in the ICU,
and in-hospital stay time (<xref ref-type="table" rid="t01">Table 1</xref>). Mean
arterial pressure was decreased (P&#x0003c;0.01) and heart rate was increased (P&#x0003c;0.01) in
a similar manner in the two anesthetic groups after surgery compared with baseline
(Supplementary Figure S1). Hemodilution was similar in both anesthetic groups. The
hematocrit was significantly decreased after surgery and then increased in the 24-h
recovery period after surgery (two-way ANOVA, P&#x0003c;0.0001; Supplementary Figure S1).</p><p>
<table-wrap id="t01" orientation="portrait" position="float"><graphic xlink:href="1414-431X-bjmbr-1414-431X20154646-gt001"/></table-wrap>
</p><p>Plasma IL-1 (<xref ref-type="fig" rid="f01">Figure 1A and B</xref>) and IL-6 (<xref ref-type="fig" rid="f01">Figure 1C and D</xref>) levels were increased after surgery
compared with baseline, but this increase was proportionally higher in the TIVA group
compared with the TIVA+DEX group (both P&#x0003c;0.0001). Plasma IL-10 levels were decreased
after CABG surgery compared with baseline (P&#x0003c;0.0001; <xref ref-type="fig" rid="f01">Figure 1E and F</xref>). Anesthesia with TIVA or TIVA+DEX did not modify the rate of
decrease in IL-10 levels (<xref ref-type="fig" rid="f01">Figure 1E and F</xref>).</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Interleukin (IL)-1 (A,B), IL-6 (C,D), and IL-10 (E,F) levels were measured in
patients who underwent coronary arterial bypass graft surgery under
mini-cardiopulmonary bypass, using two different types of anesthesia (conventional
total intravenous anesthesia [TIVA; n=11] and TIVA+DEX [n=12]). Two-way ANOVA
showed a significant interaction between type of anesthesia and sampling time for
IL-1 and IL-6 levels (P&#x0003c;0.0001). This finding indicated that the increase in
IL-1 and IL-6 levels as a function of time after surgery was attenuated in
patients who were anesthetized with TIVA+DEX compared with those who received only
TIVA. Two-way ANOVA of IL-10 levels only showed a significant main effect of
sampling time (P&#x0003c;0.0001) with a similar and progressive decrease of IL-10 in
both anesthetic groups.</title></caption><graphic xlink:href="1414-431X-bjmbr-1414-431X20154646-gf001"/></fig><p>Plasma INF-&#x003b3; levels (<xref ref-type="fig" rid="f02">Figure 2A and B</xref>) and TNF-&#x003b1;
levels (<xref ref-type="fig" rid="f02">Figure 2C and D</xref>) were increased after
surgery compared with baseline. However, the increase in INF-&#x003b3; and TNF-&#x003b1; levels was
proportionally higher in the TIVA group than in the TIVA+DEX group (<xref ref-type="fig" rid="f02">Figure 2A-D</xref>; both P&#x0003c;0.0001).</p><fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>
<italic>A, B,</italic> Plasma &#x003b3;-interferon (INF-&#x003b3;) and <italic>C</italic>,
<italic>D</italic>, tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) levels in patients who
underwent coronary arterial bypass graft surgery under mini-cardiopulmonary
bypass, using two different types of anesthesia (conventional total intravenous
anesthesia [TIVA; n=11] and TIVA+DEX [n=12]). Two-way ANOVA showed a significant
type of anesthesia versus sampling time interaction for INF-&#x003b3; and TNF-&#x003b1; levels
(P&#x0003c;0.0001). This finding indicated that the increase in INF-&#x003b3; and TNF-&#x003b1; levels
after surgery was lower in patients who were anesthetized with TIVA+DEX than in
patients who received only TIVA.</title></caption><graphic xlink:href="1414-431X-bjmbr-1414-431X20154646-gf002"/></fig><p>Plasma C-reactive protein levels were significantly increased only after 24 h
(Supplementary Figure S2; P&#x0003c;0.0001), CPK levels gradually increased after surgery
(Supplementary Figure S2C and D), and CPK-MB levels immediately increased after the end
of surgery compared with baseline (Supplementary Figure S2E and F). However, the changes
in these markers were similar between the two anesthetic groups. Troponin, cortisol, and
glucose levels were increased after surgery compared with baseline, but no differences
were observed between the two anesthetic procedures (Supplementary Figure S3).</p><p>TBARS in erythrocytes were increased after surgery compared with baseline. This increase
in TBARS was proportionally higher in the TIVA+DEX group than in the TIVA group (<xref ref-type="fig" rid="f03">Figure 3A and B</xref>; P&#x0003c;0.01). ALA-D activity was
decreased after surgery compared with baseline, and this decrease was lowest 24 h after
surgery in both experimental groups (<xref ref-type="fig" rid="f03">Figure 3C and
D</xref>; P&#x0003c;0.001).</p><fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>
<italic>A</italic>, <italic>B</italic>, Thiobarbituric reactive substances (TBARS)
and <italic>C</italic>, <italic>D</italic>, &#x003b4;-aminolevulinate dehydratase (ALA-D)
enzyme activity of erythrocytes in patients who underwent coronary arterial bypass
graft surgery under mini-cardiopulmonary bypass, using two different types of
anesthesia (conventional total intravenous anesthesia [TIVA; n=11] and TIVA+DEX
[n=12]). For TBARS, two-way ANOVA showed a significant sampling time versus type
or anesthesia interaction (P&#x0003c;0.001). For ALA-D activity, two-way ANOVA showed
only a significant main effect of time (P&#x0003c;0.0001).</title></caption><graphic xlink:href="1414-431X-bjmbr-1414-431X20154646-gf003"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>The main finding of the present study was that DEX (as a component of TIVA) modified the
inflammatory response in CABG surgery under mini-CPB. DEX use was associated with a
reduced increase in plasma IL-1, IL-6, TNF-&#x003b1;, and INF-&#x003b3; levels compared with
conventional TIVA. In both groups of patients, a similar postoperative decrease in IL-10
levels occurred. In contrast to our expectation, DEX use was associated with an increase
in TBARS levels in erythrocytes after surgery compared with the TIVA group. The decrease
in activity of ALA-D, which is considered as a putative marker of oxidative stress
(<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>), was similar in both anesthetic groups. Taken together, these results
indicated dissociation between changes in the levels of inflammatory markers and
oxidative stress in erythrocytes of patients who were subjected to CABG surgery.</p><p>There are limited data on the effects of DEX and other &#x003b1;-2 adrenergic receptor agonists
on cytokines (<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B23" ref-type="bibr">23</xref>
<xref rid="B24" ref-type="bibr">24</xref>
<xref rid="B25" ref-type="bibr">25</xref>
<xref rid="B26" ref-type="bibr">26</xref>
<xref rid="B27" ref-type="bibr">27</xref>
<xref rid="B28" ref-type="bibr">28</xref>
<xref rid="B29" ref-type="bibr">29</xref>
<xref rid="B30" ref-type="bibr">30</xref>) and TNF-&#x003b1; production by macrophages (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>).
Taniguchi et al. (<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>) demonstrated that DEX has inhibitory effects on cytokine release
triggered by endotoxemia. Therefore, one of the mechanisms of anti-inflammatory effects
of DEX may be via modulation of cytokine production by macrophages and monocytes.
Similarly, Hofer et al. (<xref rid="B29" ref-type="bibr">29</xref>) showed that
clonidine decreased proinflammatory cytokine production in experimental sepsis. They
observed an improvement in survival after induction of sepsis in mice by preventive
administration of clonidine or DEX (<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>). In accordance with our findings, they reported
a reduction in the plasma proinflammatory mediators IL-1&#x003b2;, IL-6, and TNF-&#x003b1; (<xref rid="B29" ref-type="bibr">29</xref>). They suggested the use of central-acting
&#x003b1;2-adrenergic receptor agonists as a preventive therapeutic option in major surgery. In
the current study, patients did not have sepsis, but CABG surgery resulted in a high
immunological stress response, which to some extent is similar to SIRS. Of particular
therapeutic significance, DEX (TIVA+DEX) hampered the surgery-induced increase in IL-1,
IL-6, INF-&#x003b3;, and TNF-&#x003b1; levels compared with conventional TIVA. Notably, one study showed
that DEX decreased the inflammatory response in ICU patients with severe sepsis more
than did propofol infusion (<xref rid="B30" ref-type="bibr">30</xref>), when TNF-&#x003b1;,
IL-1, and IL-6 were used as endpoints of inflammation.</p><p>Recently, Peng et al. (<xref rid="B31" ref-type="bibr">31</xref>) demonstrated that DEX
was a potent suppressor of lipopolysaccharide-induced inflammation in activated
microglia and may be a potential therapeutic agent for the treatment of intensive care
unit delirium. They investigated the effects of DEX on the production of proinflammatory
mediators in lipopolysaccharide-stimulated microglia and found that DEX (10 and 100
ng/mL) inhibited the release of nitric oxide, prostaglandin E2, interleukin 1&#x003b2;, and
TNF-&#x003b1;. The dosage that we used in the current study can be considered low to moderate.
Nevertheless, this dose diminished the surgery-induced increase in plasma IL-1, IL-6,
TNF-&#x003b1;, and INF-&#x003b3; levels.</p><p>DEX can inhibit cortisol synthesis, but this has not been reported in short-term use in
humans (<xref rid="B32" ref-type="bibr">32</xref>
<xref rid="B33" ref-type="bibr">33</xref>
<xref rid="B34" ref-type="bibr">34</xref>). In fact, Bekker et al. (<xref rid="B35" ref-type="bibr">35</xref>) hypothesized that intraoperative administration
of DEX reduces the stress response and improves the quality of recovery in patients
undergoing major spinal surgery by negatively modulating the increase in plasma cortisol
levels observed after surgery (<xref rid="B35" ref-type="bibr">35</xref>). However, we
did not observe any differences in increased levels of cortisol and glucose between the
two anesthetic groups of patients (for details, see Supplementary material).</p><p>In this study, we demonstrated that DEX attenuated the increase in IL-1, IL-6, TNF-&#x003b1;,
and INF-&#x003b3; levels in patients under CABG surgery with mini-CPB. One of the limitations of
the present study was the small number of enrolled patients. However, the variability in
inflammatory markers was satisfactory. Furthermore, the dose of DEX used was low. Future
studies on the anti-inflammatory effect of DEX at high doses need to be performed.
Indeed, the safety and efficacy of high doses of DEX in patients undergoing major
surgeries need to be determined to assess its appropriateness as an ideal
anti-inflammatory anesthetic. In short, based on our results, we conclude that DEX is an
important anesthetic adjuvant in cardiac surgery.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data"><media mime-subtype="pdf" mimetype="application" xlink:href="1414-431X-bjmbr-1414-431X20154646-S1.pdf" orientation="portrait" id="d36e531" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by Funda&#x000e7;&#x000e3;o de Amparo a Pesquisa do Estado do Rio Grande do Sul
(FAPERGS), Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES), Conselho
Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq), Rede Instituto Brasileiro
de Neuroci&#x000ea;ncia [(FINEP (IBN-Net) #01.06.0842-00], FAPERGS-PRONEX-CNPQ, Instituto
Nacional de Ci&#x000ea;ncia e Tecnologia em Excitotoxicidade e Neuroprote&#x000e7;&#x000e3;o (INCT-EN), and
FAPERGS-PQ-GAUCHO-2014-2015 (2251/14-7).</p></ack><ref-list><title>References</title><ref id="B01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>M</given-names></name><name><surname>von Heymann</surname><given-names>C</given-names></name><name><surname>von Dossow</surname><given-names>V</given-names></name><name><surname>Spaethe</surname><given-names>C</given-names></name><name><surname>Konertz</surname><given-names>WF</given-names></name><name><surname>Jain</surname><given-names>U</given-names></name><etal/></person-group><article-title>Increased interleukin-6 after cardiac surgery predicts
infection</article-title><source>Anesth Analg</source><year>2006</year><volume>102</volume><fpage>1623</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1213/01.ane.0000215998.21739.48</pub-id><pub-id pub-id-type="pmid">16717298</pub-id></element-citation></ref><ref id="B02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murkin</surname><given-names>JM</given-names></name></person-group><article-title>Panvascular inflammation and mechanisms of injury in
perioperative CNS outcomes</article-title><source>Semin Cardiothorac Vasc Anesth</source><year>2010</year><volume>14</volume><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1177/1089253210378177</pub-id><pub-id pub-id-type="pmid">20656746</pub-id></element-citation></ref><ref id="B03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>S</given-names></name><name><surname>LeClerc</surname><given-names>JL</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group><article-title>Inflammatory response to cardiopulmonary bypass:
mechanisms involved and possible therapeutic strategies</article-title><source>Chest</source><year>1997</year><volume>112</volume><fpage>676</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1378/chest.112.3.676</pub-id><pub-id pub-id-type="pmid">9315800</pub-id></element-citation></ref><ref id="B04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matata</surname><given-names>BM</given-names></name><name><surname>Sosnowski</surname><given-names>AW</given-names></name><name><surname>Galinanes</surname><given-names>M</given-names></name></person-group><article-title>Off-pump bypass graft operation significantly reduces
oxidative stress and inflammation</article-title><source>Ann Thorac Surg</source><year>2000</year><volume>69</volume><fpage>785</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(99)01420-4</pub-id><pub-id pub-id-type="pmid">10750762</pub-id></element-citation></ref><ref id="B05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>R</given-names></name></person-group><article-title>Identification of inflammatory mediators and their
modulation by strategies for the management of the systemic inflammatory response
during cardiac surgery</article-title><source>J Cardiothorac Vasc Anesth</source><year>2015</year><volume>27</volume><fpage>983</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2012.09.013</pub-id><pub-id pub-id-type="pmid">23276596</pub-id></element-citation></ref><ref id="B06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>JP</given-names></name><name><surname>Parks</surname><given-names>R</given-names></name><name><surname>Savino</surname><given-names>JS</given-names></name><name><surname>Friedman</surname><given-names>AS</given-names></name><name><surname>Koch</surname><given-names>C</given-names></name><name><surname>Mangano</surname><given-names>DT</given-names></name><etal/></person-group><article-title>Atrial fibrillation following coronary artery bypass
graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study
of Perioperative Ischemia Research Group</article-title><source>JAMA</source><year>1996</year><volume>276</volume><fpage>300</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1001/jama.1996.03540040044031</pub-id><pub-id pub-id-type="pmid">8656542</pub-id></element-citation></ref><ref id="B07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>EA</given-names></name></person-group><article-title>Off-pump coronary-artery bypass surgery</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>379</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">12556540</pub-id></element-citation></ref><ref id="B08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodemeister</surname><given-names>S</given-names></name><name><surname>Duquesne</surname><given-names>M</given-names></name><name><surname>Adolph</surname><given-names>M</given-names></name><name><surname>Nohr</surname><given-names>D</given-names></name><name><surname>Biesalski</surname><given-names>HK</given-names></name><name><surname>Unertl</surname><given-names>K</given-names></name></person-group><article-title>Massive and long-lasting decrease in vitamin C plasma
levels as a consequence of extracorporeal circulation</article-title><source>Nutrition</source><year>2014</year><volume>30</volume><fpage>673</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2013.10.026</pub-id><pub-id pub-id-type="pmid">24631388</pub-id></element-citation></ref><ref id="B09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulow</surname><given-names>NMH</given-names></name><name><surname>Colpo</surname><given-names>E</given-names></name><name><surname>Duarte</surname><given-names>MF</given-names></name><name><surname>Correa</surname><given-names>EFM</given-names></name><name><surname>Schlosser</surname><given-names>RS</given-names></name><name><surname>Lauda</surname><given-names>A</given-names></name><etal/></person-group><article-title>Inflammatory response in patients under coronary artery
bypass grafting surgery and clinical implications: a review of the relevance of
dexmedetomidine use</article-title><source>ISRN Anesthesiology</source><year>2014</year><pub-id pub-id-type="doi">10.1155/2014/905238</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aantaa</surname><given-names>R</given-names></name><name><surname>Jalonen</surname><given-names>J</given-names></name></person-group><article-title>Perioperative use of alpha2-adrenoceptor agonists and
the cardiac patient</article-title><source>Eur J Anaesthesiol</source><year>2006</year><volume>23</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1017/S0265021506000378</pub-id><pub-id pub-id-type="pmid">16507202</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corcoran</surname><given-names>TB</given-names></name><name><surname>Engel</surname><given-names>A</given-names></name><name><surname>Sakamoto</surname><given-names>H</given-names></name><name><surname>O'Shea</surname><given-names>A</given-names></name><name><surname>O'Callaghan-Enright</surname><given-names>S</given-names></name><name><surname>Shorten</surname><given-names>GD</given-names></name></person-group><article-title>The effects of propofol on neutrophil function, lipid
peroxidation and inflammatory response during elective coronary artery bypass
grafting in patients with impaired ventricular function</article-title><source>Br J Anaesth</source><year>2006</year><volume>97</volume><fpage>825</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1093/bja/ael270</pub-id><pub-id pub-id-type="pmid">17032661</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Memis</surname><given-names>D</given-names></name><name><surname>Hekimoglu</surname><given-names>S</given-names></name><name><surname>Vatan</surname><given-names>I</given-names></name><name><surname>Yandim</surname><given-names>T</given-names></name><name><surname>Yuksel</surname><given-names>M</given-names></name><name><surname>Sut</surname><given-names>N</given-names></name></person-group><article-title>Effects of midazolam and dexmedetomidine on inflammatory
responses and gastric intramucosal pH to sepsis, in critically ill
patients</article-title><source>Br J Anaesth</source><year>2007</year><volume>98</volume><fpage>550</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1093/bja/aem017</pub-id><pub-id pub-id-type="pmid">17363413</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nader</surname><given-names>ND</given-names></name><name><surname>Ignatowski</surname><given-names>TA</given-names></name><name><surname>Kurek</surname><given-names>CJ</given-names></name><name><surname>Knight</surname><given-names>PR</given-names></name><name><surname>Spengler</surname><given-names>RN</given-names></name></person-group><article-title>Clonidine suppresses plasma and cerebrospinal fluid
concentrations of TNF-alpha during the perioperative period</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><fpage>363</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1213/00000539-200108000-00026</pub-id><pub-id pub-id-type="pmid">11473862</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>GT</given-names></name><name><surname>Davidson</surname><given-names>M</given-names></name><name><surname>Fisher</surname><given-names>E</given-names></name><name><surname>Mathisen</surname><given-names>J</given-names></name><name><surname>Thomson</surname><given-names>G</given-names></name><etal/></person-group><article-title>Efficacy of dexmedetomidine compared with midazolam for
sedation in adult intensive care patients: a systematic review</article-title><source>Br J Anaesth</source><year>2013</year><volume>111</volume><fpage>703</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1093/bja/aet194</pub-id><pub-id pub-id-type="pmid">23748199</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>FW</given-names></name><name><surname>Brull</surname><given-names>R</given-names></name></person-group><article-title>Facilitatory effects of perineural dexmedetomidine on
neuraxial and peripheral nerve block: a systematic review and
meta-analysis</article-title><source>Br J Anaesth</source><year>2013</year><volume>110</volume><fpage>915</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1093/bja/aet066</pub-id><pub-id pub-id-type="pmid">23587874</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Candiotti</surname><given-names>KA</given-names></name><name><surname>Bergese</surname><given-names>SD</given-names></name><name><surname>Bokesch</surname><given-names>PM</given-names></name><name><surname>Feldman</surname><given-names>MA</given-names></name><name><surname>Wisemandle</surname><given-names>W</given-names></name><name><surname>Bekker</surname><given-names>AY</given-names></name></person-group><article-title>Monitored anesthesia care with dexmedetomidine: a
prospective, randomized, double-blind, multicenter trial</article-title><source>Anesth Analg</source><year>2010</year><volume>110</volume><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1213/ane.0b013e3181ae0856</pub-id><pub-id pub-id-type="pmid">19713256</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Can</surname><given-names>M</given-names></name><name><surname>Gul</surname><given-names>S</given-names></name><name><surname>Bektas</surname><given-names>S</given-names></name><name><surname>Hanci</surname><given-names>V</given-names></name><name><surname>Acikgoz</surname><given-names>S</given-names></name></person-group><article-title>Effects of dexmedetomidine or methylprednisolone on
inflammatory responses in spinal cord injury</article-title><source>Acta Anaesthesiol Scand</source><year>2009</year><volume>53</volume><fpage>1068</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2009.02019.x</pub-id><pub-id pub-id-type="pmid">19519725</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Tao</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name></person-group><article-title>Dexmedetomidine attenuates remote lung injury induced by
renal ischemia-reperfusion in mice</article-title><source>Acta Anaesthesiol Scand</source><year>2011</year><volume>55</volume><fpage>1272</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2011.02526.x</pub-id><pub-id pub-id-type="pmid">22092133</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleigh</surname><given-names>J</given-names></name></person-group><article-title>All hands on dex</article-title><source>Anaesthesia</source><year>2012</year><volume>67</volume><fpage>1193</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2044.2012.07334.x</pub-id><pub-id pub-id-type="pmid">22950569</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grotto</surname><given-names>D</given-names></name><name><surname>Santa Maria</surname><given-names>L</given-names></name><name><surname>Valentini</surname><given-names>J</given-names></name><name><surname>Paniz</surname><given-names>C</given-names></name><name><surname>Schmitt</surname><given-names>G</given-names></name><name><surname>Garcia</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Importance of the lipid peroxidation biomarkers and
methodological aspects for malondialdehyde quantification</article-title><source>Quimica Nova</source><year>2009</year><volume>32</volume><fpage>169</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422009000100032</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>JBT</given-names></name><name><surname>Saraiva</surname><given-names>RA</given-names></name><name><surname>Garcia</surname><given-names>SC</given-names></name><name><surname>Gravina</surname><given-names>FS</given-names></name><name><surname>Nogueira</surname><given-names>CW</given-names></name></person-group><article-title>Aminolevulinate dehydratase (&#x003b4;-ALA-D) as marker protein
of intoxication with metals and other pro-oxidant situations</article-title><source>Toxicol Res</source><year>2012</year><volume>1</volume><fpage>85</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1039/C2TX20014G</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>JBT</given-names></name><name><surname>Bulow</surname><given-names>NMH</given-names></name><name><surname>Correa</surname><given-names>EF</given-names></name><name><surname>Scholze</surname><given-names>C</given-names></name><name><surname>Nogueira</surname><given-names>CW</given-names></name><name><surname>Barbosa</surname><given-names>NBV</given-names></name></person-group><article-title>Dexmedetomidine protects blood &#x003b4;-minolevulinate
dehydratase from inactivation caused by hyperoxygenation in total intravenous
anesthesia</article-title><source>Hum Exp Tox</source><year>2011</year><volume>30</volume><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1177/0960327110372399</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straub</surname><given-names>RH</given-names></name><name><surname>Herrmann</surname><given-names>M</given-names></name><name><surname>Berkmiller</surname><given-names>G</given-names></name><name><surname>Frauenholz</surname><given-names>T</given-names></name><name><surname>Lang</surname><given-names>B</given-names></name><name><surname>Scholmerich</surname><given-names>J</given-names></name><etal/></person-group><article-title>Neuronal regulation of interleukin 6 secretion in murine
spleen: adrenergic and opioidergic control</article-title><source>J Neurochem</source><year>1997</year><volume>68</volume><fpage>1633</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.68041633.x</pub-id><pub-id pub-id-type="pmid">9084435</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Xia</surname><given-names>Z</given-names></name></person-group><article-title>Protective effects of dexmedetomidine on blunt chest
trauma-induced pulmonary contusion in rats</article-title><source>J Trauma Acute Care Surg</source><year>2013</year><volume>74</volume><fpage>524</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1097/TA.0b013e31827d5de3</pub-id><pub-id pub-id-type="pmid">23354246</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kidani</surname><given-names>Y</given-names></name><name><surname>Kanakura</surname><given-names>H</given-names></name><name><surname>Takemoto</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name></person-group><article-title>Effects of dexmedetomidine on mortality rate and
inflammatory responses to endotoxin-induced shock in rats</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><fpage>1322</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000128579.84228.2A</pub-id><pub-id pub-id-type="pmid">15187514</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kurita</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Inaba</surname><given-names>H</given-names></name></person-group><article-title>Dose- and time-related effects of dexmedetomidine on
mortality and inflammatory responses to endotoxin-induced shock in
rats</article-title><source>J Anesth</source><year>2008</year><volume>22</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1007/s00540-008-0611-9</pub-id><pub-id pub-id-type="pmid">18685927</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>YC</given-names></name><name><surname>Tsai</surname><given-names>PS</given-names></name><name><surname>Huang</surname><given-names>CJ</given-names></name></person-group><article-title>Effects of dexmedetomidine on regulating
endotoxin-induced up-regulation of inflammatory molecules in murine
macrophages</article-title><source>J Surg Res</source><year>2009</year><volume>154</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2008.07.010</pub-id><pub-id pub-id-type="pmid">19181340</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szelenyi</surname><given-names>J</given-names></name><name><surname>Kiss</surname><given-names>JP</given-names></name><name><surname>Vizi</surname><given-names>ES</given-names></name></person-group><article-title>Differential involvement of sympathetic nervous system
and immune system in the modulation of TNF-alpha production by alpha2- and
beta-adrenoceptors in mice</article-title><source>J Neuroimmunol</source><year>2000</year><volume>103</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/S0165-5728(99)00234-9</pub-id><pub-id pub-id-type="pmid">10674987</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>S</given-names></name><name><surname>Steppan</surname><given-names>J</given-names></name><name><surname>Wagner</surname><given-names>T</given-names></name><name><surname>Funke</surname><given-names>B</given-names></name><name><surname>Lichtenstern</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><etal/></person-group><article-title>Central sympatholytics prolong survival in experimental
sepsis</article-title><source>Crit Care</source><year>2009</year><volume>13</volume><fpage>R11</fpage><pub-id pub-id-type="doi">10.1186/cc7709</pub-id><pub-id pub-id-type="pmid">19196475</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasdogan</surname><given-names>M</given-names></name><name><surname>Memis</surname><given-names>D</given-names></name><name><surname>Sut</surname><given-names>N</given-names></name><name><surname>Yuksel</surname><given-names>M</given-names></name></person-group><article-title>Results of a pilot study on the effects of propofol and
dexmedetomidine on inflammatory responses and intraabdominal pressure in severe
sepsis</article-title><source>J Clin Anesth</source><year>2009</year><volume>21</volume><fpage>394</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.jclinane.2008.10.010</pub-id><pub-id pub-id-type="pmid">19833271</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name><name><surname>Wang</surname><given-names>CY</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name></person-group><article-title>Dexmedetomidine attenuates lipopolysaccharide-induced
proinflammatory response in primary microglia</article-title><source>J Surg Res</source><year>2013</year><volume>179</volume><fpage>e219</fpage><lpage>e225</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2012.05.047</pub-id><pub-id pub-id-type="pmid">22683080</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maze</surname><given-names>M</given-names></name><name><surname>Virtanen</surname><given-names>R</given-names></name><name><surname>Daunt</surname><given-names>D</given-names></name><name><surname>Banks</surname><given-names>SJ</given-names></name><name><surname>Stover</surname><given-names>EP</given-names></name><name><surname>Feldman</surname><given-names>D</given-names></name></person-group><article-title>Effects of dexmedetomidine, a novel imidazole
sedative-anesthetic agent, on adrenal steroidogenesis: <italic>in vivo</italic>
and <italic>in vitro</italic> studies</article-title><source>Anesth Analg</source><year>1991</year><volume>73</volume><fpage>204</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">1649559</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>RM</given-names></name><name><surname>Bryant</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>GM</given-names></name><name><surname>Grounds</surname><given-names>RM</given-names></name></person-group><article-title>Effects of dexmedetomidine on adrenocortical function,
and the cardiovascular, endocrine and inflammatory responses in post-operative
patients needing sedation in the intensive care unit</article-title><source>Br J Anaesth</source><year>2001</year><volume>86</volume><fpage>650</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1093/bja/86.5.650</pub-id><pub-id pub-id-type="pmid">11575340</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulow</surname><given-names>NM</given-names></name><name><surname>Barbosa</surname><given-names>NV</given-names></name><name><surname>Rocha</surname><given-names>JB</given-names></name></person-group><article-title>Opioid consumption in total intravenous anesthesia is
reduced with dexmedetomidine: a comparative study with remifentanil in gynecologic
videolaparoscopic surgery</article-title><source>J Clin Anesth</source><year>2007</year><volume>19</volume><fpage>280</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.jclinane.2007.01.004</pub-id><pub-id pub-id-type="pmid">17572323</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekker</surname><given-names>A</given-names></name><name><surname>Haile</surname><given-names>M</given-names></name><name><surname>Kline</surname><given-names>R</given-names></name><name><surname>Didehvar</surname><given-names>S</given-names></name><name><surname>Babu</surname><given-names>R</given-names></name><name><surname>Martiniuk</surname><given-names>F</given-names></name><etal/></person-group><article-title>The effect of intraoperative infusion of dexmedetomidine
on the quality of recovery after major spinal surgery</article-title><source>J Neurosurg Anesthesiol</source><year>2013</year><volume>25</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1097/ANA.0b013e31826318af</pub-id><pub-id pub-id-type="pmid">22824921</pub-id></element-citation></ref></ref-list></back></article>